Kimberley Lee, MD

Kimberley T. Lee, Brian Lee Egleston, Dominique Fetzer, Sarah Brown, Susan M. Domchek, Linda Fleisher, Kuang-Yi Wen, Lynne I. Wagner, J. Scott Roberts, Cara Cacioppo, Janice Christiansen, Sarah Howe, Elisabeth Wood, Michelle Weinberg, Kelsey Karpink, Enida F. Selmani, Justin Feng, Samantha John, Evelyn Mastaglio, and Angela R. Bradbury, eREACH2 Group A randomized non-inferiority trial of an eHealth delivery alternative for cancer genetic testing for hereditary cancer (eREACH2). , J Clin Oncol, 44(16): 2026

Lee KT, Hu B, Martinez Tyson D, Geiss C, Vadaparampil ST, Jim HSL, Gwede CK, Soliman HH, Henry NL, Hershman DL. A mixed-methods study characterizing experiences of medical oncologists' use of gonadotropin-releasing hormone agonists for treatment of breast cancer. , Breast Cancer Res Treat. , 212(3): 2025

Lee KT, McLeod B, Egleston B, Brown S, Howe S, Fetzer D, Gutstein L, Cacioppo C, Clark D, Domchek SM, Ebrahimzadeh J, Falcone D, Ofidis D, Griffin H, Mim R, Hernandez S, Fleisher L, Karpink K, Selmani E, Tahsin A, Wagner L, Weinberg M, Yi-Wen K, Wood E, Bradbury AR. An eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients With Metastatic Cancers: Protocol for a Randomized Trial , JMIR Res Protoc, 14: 2025,e72515

Lee KT, Geiss C, Fulton HJ, Charles D, Gonzalez BD, Jim HSL, Henry NL, Hershman DL, Tworoger SS, Bradbury A, Fayanju OM, Vadaparampil ST, Gwede CK. Hidden Costs of Endocrine Therapy for Black Breast Cancer Survivors: A Qualitative Examination of Patient and Provider Experiences. , Clin Breast Cancer. : 2025

Ahmed KA, Kim Y, Armaghani AJ, Arrington JA, Costa RL, Czerniecki BJ, Diaz R, Dowell RA, Extermann M, Forsyth PA, Lee KT, Loftus L, Mills MN, Phuoc VH, Rosa M, Soliman HH, Sam CS, Washington IR, Soyano AE, Han HS. Phase II trial of brain MRI surveillance in stage IV breast cancer. , Neuro Oncol., 30(27): 2025,1550-1558

Lee KT, Maconi M, Geiss C, Jim HSL, Gwede CK, Soliman HH, Vadaparampil S Decision-making and Understanding of Ovarian Function Suppression Treatments Amongst Survivors of HR+ Breast Cancer. , Society of Behavioral Medicine 46th Annual Meeting, San Francisco, CA.: 2025

Kimberley T. Lee, Brian Egleston, Sarah Brown, Sarah Howe, Dominique Fetzer, Lauren Gutstein, Cara Cacioppo, Dana Clark, Susan Domchek, Jessica Ebrahimzadeh, Dana Falcone, Demetrios Ofidis, Hannah Griffin, Rajia Mim, Santina Hernandez, Linda Fleisher, Kelsey Karpink, Enida Selmani, Aysha Tahsin, Lynne Wagner, Michelle Weinberg, Kuang Yi-Wen, Elisabeth Wood, Angela R. Bradbury. The eREACH Study: A Randomized Study of an eHEALTH Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients with Metastatic Cancers. , JMIR Res Protoc (forthcoming): 2025

Lee KT, Hu E, Henry NL, Hershman D, Hoogland AI, Gwede CK, Jim HSL, Soliman HH, Vadaparampil ST. Exploring Oncologists’ Experiences with Ovarian Function Suppression for Breast Cancer. , American Society of Preventive Oncology, Annual Meeting.: 2025

Angela R. Bradbury, Brian L. Egleston, Sarah Brown, Briana Mcleod, Dominique Fetzer, Cara Cacioppo, Janice Christiansen, Dana Farengo-Clark, Susan M. Domchek, Jessica E. Ebrahimzadeh, Linda Fleisher, Sarah Howe, Kelsey Karpink, Kimberley T. Lee, Enida F. Selmani, Lynne I. Wagner, Michelle Weinberg, Kuang-Yi Wen, Elisabeth Wood, Penn Telegenetics Program. The eREACH study: A randomized study of an eHEALTH delivery alternative for cancer genetic testing for hereditary predisposition in patients with metastatic cancers. , J Clin Oncol, 43(16_suppl): 2025,10502

Geiss C, Blackwell RM, Maconi ML, Buhlmann M, Welniak T, Lee KT, Kirtane K, Gonzalez BD. Assessing feasibility, appropriateness, and acceptability of digital patient journaling for qualitative data collection in cancer research. , 46th Annual Meeting & Scientific Sessions of the Society of Behavioral Medicine: 2025